FDA Inspection 765467 - Onyx Pharmaceuticals, Inc., a Subsidiary of Amgen, Inc. - January 20, 2012

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Onyx Pharmaceuticals, Inc., a Subsidiary of Amgen, Inc., with an inspection on January 20, 2012, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Onyx Pharmaceuticals, Inc., a Subsidiary of Amgen, Inc.
Inspection Date: January 20, 2012
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · 1a73ad03-4282-4023-aab8-00cb7d7d3c5b

Violation Codes1

21 CFR 312.50

Full citation text and observation details available on the Dashboard.

FDA Inspection

Onyx Pharmaceuticals, Inc., a Subsidiary of Amgen, Inc.January 20, 2012